obesity drug news today glp-1 september 29 2025 Serena Williams paid endorsement for a GLP-1 company got a lot of attention but I feel the real issues were not discussed. Whether she had complications of Weight-loss drugs such as Ozempic

The obesity Phase 3 studies and the first topline readout The obesity backbone includes 76-week efficacy-and-safety trials in adults with overweight or obesity without type 2 diabetes (SYNCHRONIZE-1, NCT06066515) and with type 2 diabetes (SYNCHRONIZE-2, NCT06066528), plus region-specific studies

Implications and Future Research GLP-1 agonists offer significant benefits for weight loss and metabolic health, but their potential effects on sexual function should not be overlooked

Bruising after semaglutide injections is a localized reaction that occurs when small blood vessels beneath the skin are damaged during needle insertion

Rybelsus (Semaglutida) Rybelsus es un medicamento en comprimidos orales diarios para tratar la diabetes tipo 2 que ayuda a controlar los niveles de azcar en sangre

This allows researchers to isolate metabolic signaling effects without confounding endocrine responses, making AOD 9604 a useful model for studying localized metabolic regulation

The all-in-one experience: Med spas, gyms, wellness centers and retreats have exploded in growth